COVID-19 mRNA vaccination leading to CNS inflammation: a case series

The availability of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID-19) pandemic. Vaccine safety and efficacy has not been established in individuals with chronic autoimmune diseases such as mu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology Jg. 269; H. 3; S. 1093 - 1106
Hauptverfasser:	Khayat-Khoei, Mahsa, Bhattacharyya, Shamik, Katz, Joshua, Harrison, Daniel, Tauhid, Shahamat, Bruso, Penny, Houtchens, Maria K., Edwards, Keith R., Bakshi, Rohit
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2022 Springer Nature B.V
Schlagworte:	Adult Autoimmune diseases Central nervous system Coronaviruses Corticosteroids COVID-19 COVID-19 Vaccines Demyelination Female Gait Herd immunity Humans Inflammation Magnetic resonance imaging Medicine Medicine & Public Health Middle Aged Morbidity mRNA Multiple sclerosis Neurology Neuromyelitis Neuroradiology Neurosciences Optic nerve Original Communication Pandemics Patients RNA, Messenger SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Sphincter Spinal cord Vaccination Vaccines Young Adult COVID-19 Multiple sclerosis Demyelination Vaccination Neuromyelitis optica Inflammation SAR-CoV-2
ISSN:	0340-5354, 1432-1459, 1432-1459
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!